Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria

BACKGROUND: Emergence of anti-malarial drug resistance and perpetual increase in malaria incidence necessitates the development of novel anti-malarials. Histone deacetylases (HDAC) has been shown to be a promising target for malaria, despite this, there are no HDAC inhibitors in clinical trials for...

Descripción completa

Detalles Bibliográficos
Autores principales: Potluri, Vijay, Shandil, Radha K., Gavara, R., Sambasivam, Ganesh, Campo, Brice, Wittlin, Sergio, Narayanan, Shridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549214/
https://www.ncbi.nlm.nih.gov/pubmed/33046062
http://dx.doi.org/10.1186/s12936-020-03421-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549214/
https://www.ncbi.nlm.nih.gov/pubmed/33046062
http://dx.doi.org/10.1186/s12936-020-03421-3

Ejemplares similares